STAT3 regulates antiviral immunity by suppressing excessive interferon signaling.

[1]  S. Finke,et al.  Phenotypic effects of mutations observed in the neuraminidase of human origin H5N1 influenza A viruses , 2023, PLoS pathogens.

[2]  Dokyun Kim,et al.  OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis , 2023, Nature Cell Biology.

[3]  Pengxiang Chang,et al.  Risk assessment of the newly emerged H7N9 avian influenza viruses , 2022, bioRxiv.

[4]  L. Chaloin,et al.  An evolutionarily conserved N-terminal leucine is essential for MX1 GTPase antiviral activity against different families of RNA viruses , 2022, The Journal of biological chemistry.

[5]  J. Petrini,et al.  ISG15 conjugation to proteins on nascent DNA mitigates DNA replication stress , 2022, Nature Communications.

[6]  J. Kulbacka,et al.  STAT3 and Its Pathways’ Dysregulation—Underestimated Role in Urological Tumors , 2022, Cells.

[7]  D. Tian,et al.  Modulation of SOCS3 Levels via STAT3 and Estrogen-ERαp66 Signaling during Hepatitis E Virus Replication in Hepatocellular Carcinoma Cells , 2022, Journal of virology.

[8]  G. Guo,et al.  Syk Facilitates Influenza A Virus Replication by Restraining Innate Immunity at the Late Stage of Viral Infection , 2022, Journal of virology.

[9]  G. Guo,et al.  A novel imatinib-upregulated long noncoding RNA plays a critical role in inhibition of tumor growth induced by Abl oncogenes , 2022, Molecular cancer.

[10]  A. D’Alessandro,et al.  The STAT3-MYC Axis Promotes Survival of Leukemia Stem Cells by Regulating SLC1A5 and Oxidative Phosphorylation. , 2021, Blood.

[11]  Shile Huang,et al.  Deficiency of eIF4B Increases Mouse Mortality and Impairs Antiviral Immunity , 2021, Frontiers in Immunology.

[12]  Fang Li,et al.  Long Noncoding RNA IFITM4P Regulates Host Antiviral Responses by Acting as a Competing Endogenous RNA , 2021, Journal of virology.

[13]  G. Gao,et al.  Critical role of Syk-dependent STAT1 activation in innate antiviral immunity. , 2021, Cell reports.

[14]  K. Meyer,et al.  SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells , 2020, PLoS pathogens.

[15]  R. Webby,et al.  Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes , 2020, Cell.

[16]  F. Martinon,et al.  Detection of viruses by inflammasomes , 2020, Current Opinion in Virology.

[17]  A. García-Sastre,et al.  Induction and Evasion of Type-I Interferon Responses during Influenza A Virus Infection. , 2020, Cold Spring Harbor perspectives in medicine.

[18]  Akiko Iwasaki,et al.  Type I and Type III Interferons – Induction, Signaling, Evasion, and Application to Combat COVID-19 , 2020, Cell Host & Microbe.

[19]  M. Llorian,et al.  Type I and III interferons disrupt lung epithelial repair during recovery from viral infection , 2020, Science.

[20]  F. Granucci,et al.  Type III interferons disrupt the lung epithelial barrier upon viral recognition , 2020, Science.

[21]  J. Rehwinkel,et al.  RIG-I-like receptors: their regulation and roles in RNA sensing , 2020, Nature Reviews Immunology.

[22]  F. Granucci,et al.  Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion , 2019, The Journal of experimental medicine.

[23]  J. Schoggins.  Interferon-Stimulated Genes: What Do They All Do? , 2019, Annual review of virology.

[24]  Lianfeng Zhang,et al.  Influenza Virus-Induced Robust Expression of SOCS3 Contributes to Excessive Production of IL-6 , 2019, Front. Immunol..

[25]  Andrew Macdonald,et al.  Autocrine STAT3 activation in HPV positive cervical cancer through a virus-driven Rac1—NFκB—IL-6 signalling axis , 2019, PLoS pathogens.

[26]  R. Schreiber,et al.  Interferon γ and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer Immunity. , 2019, Cold Spring Harbor perspectives in biology.

[27]  T. Baumert,et al.  Viral manipulation of STAT3: Evade, exploit, and injure , 2018, PLoS pathogens.

[28]  Jennifer R. Grandis,et al.  Targeting the IL-6/JAK/STAT3 signalling axis in cancer , 2018, Nature Reviews Clinical Oncology.

[29]  T. Waldmann,et al.  Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma , 2018, Proceedings of the National Academy of Sciences.

[30]  S. Ye,et al.  STAT3 activation in endothelial cells is important for tumor metastasis via increased cell adhesion molecule expression , 2017, Oncogene.

[31]  Song-Liang Wang,et al.  Alpha/beta interferon receptor deficiency in mice significantly enhances susceptibility of the animals to pseudorabies virus infection. , 2017, Veterinary microbiology.

[32]  A. Bowie,et al.  A novel anti-viral role for STAT3 in IFN-α signalling responses , 2016, Cellular and Molecular Life Sciences.

[33]  N. Stevenson,et al.  Advances in anti-viral immune defence: revealing the importance of the IFN JAK/STAT pathway , 2017, Cellular and Molecular Life Sciences.

[34]  J. L. Ding,et al.  Combinatorial treatment with polyI:C and anti-IL6 enhances apoptosis and suppresses metastasis of lung cancer cells , 2017, Oncotarget.

[35]  Liping Yang,et al.  Porcine Reproductive and Respiratory Syndrome Virus Antagonizes JAK/STAT3 Signaling via nsp5, Which Induces STAT3 Degradation , 2016, Journal of Virology.

[36]  E. Fodor,et al.  Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis , 2016, Nature Reviews Microbiology.

[37]  M. Chan,et al.  Highly pathogenic avian influenza H5N1 virus delays apoptotic responses via activation of STAT3 , 2016, Scientific Reports.

[38]  G. Stark,et al.  Response to interferons and antibacterial innate immunity in the absence of tyrosine‐phosphorylated STAT1 , 2016, EMBO reports.

[39]  S. Leach,et al.  Emerging Strategies for Cancer Immunoprevention , 2015, Oncogene.

[40]  S. Hur,et al.  How RIG-I like receptors activate MAVS. , 2015, Current opinion in virology.

[41]  Xinbing Sui,et al.  The role of STAT3 in autophagy , 2015, Autophagy.

[42]  Akiko Iwasaki,et al.  Innate immunity to influenza virus infection , 2014, Nature Reviews Immunology.

[43]  G. Müller-Newen,et al.  Dominant-negative activity of the STAT3-Y705F mutant depends on the N-terminal domain , 2013, Cell Communication and Signaling.

[44]  Hua Yang,et al.  New World Bats Harbor Diverse Influenza A Viruses , 2013, PLoS pathogens.

[45]  Gregory M. Frank,et al.  STAT3 Regulates Proliferation and Survival of CD8+ T Cells: Enhances Effector Responses to HSV-1 Infection, and Inhibits IL-10+ Regulatory CD8+ T Cells in Autoimmune Uveitis , 2013, Mediators of inflammation.

[46]  Justin M. Reitsma,et al.  Human Cytomegalovirus IE1 Protein Disrupts Interleukin-6 Signaling by Sequestering STAT3 in the Nucleus , 2013, Journal of Virology.

[47]  R. Levitz,et al.  Induction of IL-6 and CCL5 (RANTES) in human respiratory epithelial (A549) cells by clinical isolates of respiratory syncytial virus is strain specific , 2012, Virology Journal.

[48]  D. Levy,et al.  STAT3 Negatively Regulates Type I IFN-Mediated Antiviral Response , 2011, The Journal of Immunology.

[49]  Virginia Nguyen,et al.  Extracellular Hepatitis C Virus Core Protein Activates STAT3 in Human Monocytes/Macrophages/Dendritic Cells via an IL-6 Autocrine Pathway* , 2011, The Journal of Biological Chemistry.

[50]  Ozge Canli,et al.  gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. , 2009, Cancer cell.

[51]  N. Raab-Traub,et al.  EBV Latent Membrane Protein 1 Activates Akt, NFκB, and Stat3 in B Cell Lymphomas , 2007, PLoS pathogens.

[52]  A. Yoshimura,et al.  SOCS1-negative feedback of STAT1 activation is a key pathway in the dsRNA-induced innate immune response of human keratinocytes. , 2006, The Journal of investigative dermatology.

[53]  K. Ishii,et al.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.

[54]  Zhijian J. Chen,et al.  Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3 , 2005, Cell.

[55]  T. Hirano,et al.  Tyrosine dephosphorylation of STAT3 in SARS coronavirus‐infected Vero E6 cells , 2004, FEBS Letters.

[56]  M. Federico,et al.  Human immunodeficiency virus type 1 (HIV‐1) Nef activates STAT3 in primary human monocyte/macrophages through the release of soluble factors: involvement of Nef domains interacting with the cell endocytotic machinery , 2003, Journal of leukocyte biology.

[57]  J. Darnell,et al.  Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.

[58]  A. Siddiqui,et al.  Interaction between STAT-3 and HNF-3 Leads to the Activation of Liver-Specific Hepatitis B Virus Enhancer 1 Function , 2002, Journal of Virology.

[59]  A. Siddiqui,et al.  Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[60]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[61]  S. Akira,et al.  Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. , 1997, Proceedings of the National Academy of Sciences of the United States of America.